SCHEDULE: Joshua Mailman Reports 8.4% Stake in Jaguar Health

Joshua Mailman has reported a beneficial ownership of 8.4% of Jaguar Health, Inc.'s common stock, totaling 587,320 shares.

Summary

• Joshua Mailman has filed a Schedule 13G, reporting beneficial ownership of Jaguar Health, Inc. common stock.
• The aggregate amount beneficially owned by Mr. Mailman is 587,320 shares.
• This represents 8.4% of the class of Jaguar Health, Inc. common stock.
• Mr. Mailman holds sole voting and dispositive power over 337,321 shares, and shared voting and dispositive power over 249,999 shares.
• The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, except for activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a factual report of beneficial ownership and typically carries a neutral sentiment. The reporting of a significant stake can be seen as a minor positive for investor confidence, but the filing itself does not contain performance or strategic information to warrant a strong positive or negative score.

Positives

• A significant beneficial ownership stake of 8.4% by Joshua Mailman indicates a notable investor interest in Jaguar Health, Inc.

Negatives

• The filing does not contain information that can be categorized as negatives regarding the company's performance or outlook.

Risks

• The filing does not explicitly mention specific risks related to Jaguar Health, Inc.'s operations or financial health.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Jaguar Health, Inc.'s future outlook.

Management Comments

• I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

This filing is a standard disclosure of beneficial ownership and does not provide specific insights into broader industry trends or competitive landscape for Jaguar Health, Inc.

Stakeholder Impact

• Shareholders: The disclosure of a significant beneficial owner may instill confidence or signal potential future engagement, though the filing explicitly states no intent to influence control.

Key Dates

Keywords

Jaguar Health, JAGX, Joshua Mailman, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Shareholder Stake